Clinical Trials Logo

Sacrococcygeal Teratoma clinical trials

View clinical trials related to Sacrococcygeal Teratoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT06133036 Recruiting - Clinical trials for Sacrococcygeal Teratoma

Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)

Start date: November 2023
Phase:
Study type: Observational

Sacrococcygeal teratoma is one of the most common tumors that occur in the neonatal period. It presents either as a mass protruding from the sacrococcygeal region or as a pelviabdominal mass according to the type. Surgical excision is the main treatment, most masses are benign, however some are malignant and require radiotherapy or chemotherapy. Complications may occur due to pressure resulting from the tumor growth in the fetal period, or due to damage to important near tissues during surgical excision. Postoperative complications may be urinary as neurogenic bladder, Lower gastrointestinal as constipation, soiling or incontinence. In this work we study the outcomes of fecal continence through a questionnaire and its effect on the quality of life of the affected children.

NCT ID: NCT05182853 Completed - Neurogenic Bladder Clinical Trials

Voiding Disorders in Children After Sacrococcygeal Teratoma Resection

TSC-URO
Start date: June 16, 2021
Phase:
Study type: Observational

Sacrococcygeal teratomas are the most common neonatal tumors and require rapid and complete resection. Tumor nerve compression and pelvic surgical sequelae may lead to many and varied voiding disorders. Data concerning long-term vesico-sphincteric disorders are conflicting. Some studies find good functional results [Cozzi et al., 2008; Draper et al., 2009]. However other authors reveal neurologic bladder with detrusor sphincter dyssynergia [Hambraeus et al., 2018] and rise concerned about long-term renal function [Khanna et al., 2019; Rehfuss et al., 2020] even in the absence of clinical voiding disorders. Most of studies include young patients with other malformations such as anorectal malformations or dysraphisms which may impact the results. The main objective is to assess bladder dysfunction in children aged 6 to 18 years after isolated sacrococcygeal teratoma resection.

NCT ID: NCT04623658 Completed - Clinical trials for Sacrococcygeal Teratoma

Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma

PROSTEO
Start date: November 30, 2020
Phase:
Study type: Observational

Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. However, predicting factors of evolution, sequelae and relapse are still unreliable because of small-cohort studies. This study aims at identifying prenatal and postnatal prognostic factors of evolution of SCT during pregnancy, of postnatal relapse, and of medium and long-term sequelae (urinary, digestive, esthetic, psychologic) in order to improve parental counseling when the diagnosis of SCT is made during pregnancy.

NCT ID: NCT00780117 Completed - Clinical trials for Sacrococcygeal Teratoma

Characterization of At-risk Population for Pre-sacral Tumor in CURRARINO Syndrome

Currarino
Start date: June 2008
Phase: N/A
Study type: Observational

Contribute to support hypothesis of relationships between genes involve in oncogenesis and those involve in embryological development.